1	ETS1	ETS1	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	NFkappaB	NFkappaB	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	AP1	AP1	_	_	_	_	_	_	_
6	synergistically	synergistically	_	_	_	_	_	_	_
7	transactivate	transactivate	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	GM-CSF	GM-CSF	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	helper	helper	_	_	_	_	_	_	_
4	T	t	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	results	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	coordinate	coordinate	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	number	number	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	cytokines	cytokine	_	_	_	_	_	_	_
15	involved	involve	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	differentiation	differentiation	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	proliferation	proliferation	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	haematopoietic	haematopoietic	_	_	_	_	_	_	_
25	system	system	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
2	colony	colony	_	_	_	_	_	_	_
3	stimulating	stimulating	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	GM-CSF	GM-CSF	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	one	one	_	_	_	_	_	_	_
10	such	such	_	_	_	_	_	_	_
11	cytokine	cytokine	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	whose	whose	_	_	_	_	_	_	_
14	increased	increase	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	results	result	_	_	_	_	_	_	_
17	mostly	mostly	_	_	_	_	_	_	_
18	from	from	_	_	_	_	_	_	_
19	increases	increase	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	transcription	transcription	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Cis-acting	cis-acting	_	_	_	_	_	_	_
2	elements	element	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	NFkappaB	NFkappaB	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	AP1	ap1	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	ETS-like	ets-like	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	motifs	motif	_	_	_	_	_	_	_
11	have	have	_	_	_	_	_	_	_
12	been	be	_	_	_	_	_	_	_
13	identified	identify	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	promoter	promoter	_	_	_	_	_	_	_
17	region	region	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	GM-CSF	GM-CSF	_	_	_	_	_	_	_
21	gene	gene	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	are	be	_	_	_	_	_	_	_
25	important	important	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	essential	essential	_	_	_	_	_	_	_
28	for	for	_	_	_	_	_	_	_
29	transcriptional	transcriptional	_	_	_	_	_	_	_
30	activity	activity	_	_	_	_	_	_	_
31	following	follow	_	_	_	_	_	_	_
32	T	t	_	_	_	_	_	_	_
33	cell	cell	_	_	_	_	_	_	_
34	activation	activation	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	ETS1	ETS1	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	ETS	ETS	_	_	_	_	_	_	_
9	family	family	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	expressed	express	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	previously	previously	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	ETS1	ETS1	_	_	_	_	_	_	_
7	can	can	_	_	_	_	_	_	_
8	transactivate	transactivate	_	_	_	_	_	_	_
9	GM-CSF	GM-CSF	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	Jurkat	Jurkat	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	only	only	_	_	_	_	_	_	_
17	after	after	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	have	have	_	_	_	_	_	_	_
21	been	be	_	_	_	_	_	_	_
22	stimulated	stimulate	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	treatment	treatment	_	_	_	_	_	_	_
25	with	with	_	_	_	_	_	_	_
26	PMA	PMA	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	ionomycin	ionomycin	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	agents	agent	_	_	_	_	_	_	_
31	that	that	_	_	_	_	_	_	_
32	mimic	mimic	_	_	_	_	_	_	_
33	T	t	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	activation	activation	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	proposed	propose	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	ETS1	ETS1	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	expressed	express	_	_	_	_	_	_	_
10	constitutively	constitutively	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	Jurkat	Jurkat	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	may	may	_	_	_	_	_	_	_
16	act	act	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	concert	concert	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	PMA/ionomycin	PMA/ionomycin	_	_	_	_	_	_	_
21	inducible	inducible	_	_	_	_	_	_	_
22	factors	factor	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	ETS1	ets1	_	_	_	_	_	_	_
6	can	can	_	_	_	_	_	_	_
7	transactivate	transactivate	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	GM-CSF	GM-CSF	_	_	_	_	_	_	_
10	reporter	reporter	_	_	_	_	_	_	_
11	construct	construct	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	unstimulated	unstimulated	_	_	_	_	_	_	_
14	Jurkat	Jurkat	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	providing	provide	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	either	either	_	_	_	_	_	_	_
20	NFkappaB	NFkappaB	_	_	_	_	_	_	_
21	or	or	_	_	_	_	_	_	_
22	AP1	ap1	_	_	_	_	_	_	_
23	transcription	transcription	_	_	_	_	_	_	_
24	factors	factor	_	_	_	_	_	_	_
25	are	be	_	_	_	_	_	_	_
26	supplied	supply	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	co-transfection	co-transfection	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	confirm	confirm	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	binding	binding	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	endogenous	endogenous	_	_	_	_	_	_	_
7	NFkappaB	NFkappaB	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	AP1	AP1	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	following	follow	_	_	_	_	_	_	_
13	PMA/ionomycin	PMA/ionomycin	_	_	_	_	_	_	_
14	treatment	treatment	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Transactivation	Transactivation	_	_	_	_	_	_	_
2	by	by	_	_	_	_	_	_	_
3	ETS1	ETS1	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	NFkappaB	NFkappaB	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	AP1	AP1	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	synergistic	synergistic	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	mutation	mutation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	individual	individual	_	_	_	_	_	_	_
16	binding	bind	_	_	_	_	_	_	_
17	sites	site	_	_	_	_	_	_	_
18	reveals	reveal	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	transcriptional	transcriptional	_	_	_	_	_	_	_
22	activities	activity	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	these	these	_	_	_	_	_	_	_
25	factors	factor	_	_	_	_	_	_	_
26	are	be	_	_	_	_	_	_	_
27	interdependent	interdependent	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	ETS1	ets1	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	inducible	inducible	_	_	_	_	_	_	_
10	NFkappaB	NFkappaB	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	AP1	AP1	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	cooperate	cooperate	_	_	_	_	_	_	_
15	as	as	_	_	_	_	_	_	_
16	part	part	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	higher	high	_	_	_	_	_	_	_
20	order	order	_	_	_	_	_	_	_
21	transcriptional	transcriptional	_	_	_	_	_	_	_
22	complex	complex	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	activated	activate	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

